Significant correlations between TACC2 status and increased risk of recurrence were detected regardless of the lymph node metastasis (cases with lymph node metastasis (n = 60): P = 0.020 (Fig. 2C), and cases without lymph node metastasis (n = 94): P = 0.035) and pT (pT2‐4 cases (n = 62): P = 0.0036 (Fig. 2D), and pT1 cases (n = 92): P = 0.047). The gene discussed is TACC2; the disease is metastatic malignant neoplasm in the lymph nodes.